Zhu Ning

Materials Modification (United States) — United States

Medicine · Health Sciences

10h-index266citations29works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(14), Mycobacterium research and diagnosis(9), Pneumocystis jirovecii pneumonia detection and treatment(4), Gut microbiota and health(3), Infectious Diseases and Tuberculosis(3)

Publications29 total

Skeletal High‐Strength Nanoporous Copper and Metamaterials: The Hakka Tulou Design Heritage (Adv. Mater. 47/2025)
Advanced Materials·2025Open Access
Skeletal High‐Strength Nanoporous Copper and Metamaterials: The Hakka Tulou Design Heritage
Advanced Materials·2025Open Access
Population pharmacokinetics and dose evaluation for second-line TB drugs in patients with diabetes
The International Journal of Tuberculosis and Lung Disease·2025
A supramolecular biofilm disruptor based on cationic macrocyclic amphiphiles to eradicate bacterial biofilm-associated infections
Chemical Engineering Journal·2025· 10 cited
Subtle Brain Structure Alternations in Young Adult Patients infected with SARS-CoV-2 Omicron and Mild Symptom: A Case Control Study Using MRI
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Analysis of the relationship between sleep-related disorders and cadmium in the US population
Frontiers in Public Health·2024· 4 citedOpen Access
Comparative efficacy and safety of Faricimab and other anti-VEGF therapy for age-related macular degeneration and diabetic macular edema: A systematic review and meta-analysis of randomized clinical trials
Medicine·2023· 18 citedOpen Access
Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
Frontiers in Cellular and Infection Microbiology·2023· 17 citedOpen Access
Characteristics and Comparison of Rapidly Growing and Slowly Growing nontuberculous Mycobacterial Pulmonary Disease
International Journal of Mycobacteriology·2023· 3 citedOpen Access
Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis
Tuberculosis·2023· 6 cited
Identification and comparison of <scp><i>Chlamydia psittaci</i></scp>, <i>Legionella</i> and <i>Mycoplasma pneumonia</i> infection
The Clinical Respiratory Journal·2023· 13 citedOpen Access
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma
Cancer Medicine·2022· 6 citedOpen Access
[A comparative study on the difference of gut microbiota and its biomarkers between patients with pulmonary tuberculosis and healthy controls].
PubMed·2021· 4 cited
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
European Respiratory Journal·2021· 31 citedOpen Access
Acquired Drug Resistance During the Turnaround Time for Drug Susceptibility Testing Impacts Outcome of Tuberculosis
Research Square (Research Square)·2021· 1 citedOpen Access
Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study
International Journal of Infectious Diseases·2021· 39 citedOpen Access
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study
Clinical Microbiology and Infection·2021· 9 cited
Diagnostic Accuracy of Metagenomic Next‐Generation Sequencing in Sputum‐Scarce or Smear‐Negative Cases with Suspected Pulmonary Tuberculosis
BioMed Research International·2021· 23 citedOpen Access
Cerebral Oxygenation in Very Preterm Newborn Neonates Measured During the First Three Days of Life: Correlation with the Index of Arterial Blood Gas
SSRN Electronic Journal·2021Open Access
Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study
BMC Pulmonary Medicine·2019· 9 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yi Hu(10), Biao Xu(6), Shengqing Li(6), Xubin Zheng(5), Lina Davies Forsman(5), Daibing Zhou(5), Zhengdong Zhang(4), Wenpei Shi(3), Fan Xia(3), Meiying Wu(3), Yue Hu(3), Ziwei Bao(3), Xuliang Li(3), Xiujuan Zhang(3), Sven Hoffner(3), Stefanie Prast‐Nielsen(2), Yan Xie(2), Judith Bruchfeld(2), Jingwen Xia(2), Yazhou Gao(2)